VPS53 Suppresses Malignant Properties in Colorectal Cancer by Inducing the Autophagy Signaling Pathway

Hong Peng1, Jie Zheng2, Qiang Su3

  • 1Department of Anorectal Surgery, Nanchong Central Hospital, The Second Clinical Medical College, North Sichuan Medical College, Nanchong, Sichuan, 637000, People's Republic of China.

Oncotargets and Therapy
|October 29, 2020
PubMed
Abstract

Insights

VPS53, a Golgi-associated retrograde protein complex subunit, is downregulated in colorectal cancer (CRC). Its restoration suppresses CRC progression by enhancing autophagy, suggesting VPS53 as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • VPS53, a subunit of the Golgi-associated retrograde protein (GARP) complex, exhibits aberrant expression in various human diseases.
  • Understanding the role of VPS53 in colorectal cancer (CRC) is crucial for developing new therapeutic strategies.

Purpose of the Study:

  • To investigate the functional roles and underlying molecular mechanisms of VPS53 in colorectal cancer (CRC).
  • To explore the relationship between VPS53 and Beclin 1 in CRC progression.

Main Methods:

  • Quantitative real-time PCR (RT-qPCR) and Pearson's correlation analysis were used to assess VPS53 and Beclin 1 expression and their correlation in CRC tissues and cells.
  • Functional assays including CCK-8, flow cytometry, Transwell assays, and electron microscopy were employed to evaluate the impact of VPS53 on CRC cell proliferation, migration, invasion, apoptosis, and autophagy.
  • Western blotting was utilized to analyze the levels of autophagy-related proteins.

Main Results:

  • VPS53 and Beclin 1 were found to be downregulated in CRC tissues and cells, with a positive correlation between their expression.
  • Overexpression of VPS53 suppressed CRC cell proliferation, migration, and invasion while promoting apoptosis and autophagy.
  • VPS53 upregulated Beclin 1 and LC3BII, indicating its role in inducing autophagy, and an autophagy inhibitor attenuated VPS53's inhibitory effects on CRC progression.

Conclusions:

  • VPS53 plays a suppressive role in colorectal cancer progression by modulating the autophagy signaling pathway.
  • VPS53 represents a potential therapeutic target for colorectal cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.9K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.6K